Ramsunder cites “significant progress” in performance improvements.
Sigma Healthcare has just released its financial results for the six months to 31 July, with net profit after tax of $11.2 million, compared to a $1.5 million loss for the previous corresponding period.
CEO Vikesh Ramsunder said “we have made significant progress the last six months…service levels are at an exceptionally high standard and at the same time operating costs are down 21% as we begin to leverage the investments made over the past six years”.
Sigma’s wholesale operations are now functioning effectively, with a strong focus on boosting the group’s retail portfolio targeting 300 Amcal pharmacies and 150 Discount Drug Stores over the medium term.
The company’s new supply agreement with Chemist Warehouse for PBS medicines and FMCG products commences on 01 July 2024, with the five year deal leveraging the automation in Sigma’s distribution centres.
More details in today’s issue of Pharmacy Daily.
